Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
10/02/2003 | WO2003080557A1 Substituted 4-aminocyclohexanols |
10/02/2003 | WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use |
10/02/2003 | WO2003080181A2 Storage stable eplerenone formulation |
10/02/2003 | WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors |
10/02/2003 | WO2003080113A1 Mucosal immune vaccine for periodontal diseases |
10/02/2003 | WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
10/02/2003 | WO2003080102A1 Method of stimulating growth and resistance to diseases of aquatic organisms |
10/02/2003 | WO2003080095A1 Anti peptic ulcer activity of an extract of a plant flower woodfordia fruticosa |
10/02/2003 | WO2003080090A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450 |
10/02/2003 | WO2003080087A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation |
10/02/2003 | WO2003080086A1 A composition for treating gastric ulcer and a process for preparing the same |
10/02/2003 | WO2003080082A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment |
10/02/2003 | WO2003080081A2 Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof |
10/02/2003 | WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor |
10/02/2003 | WO2003080070A2 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
10/02/2003 | WO2003080066A1 Use of devazepide for the treatment of constipation |
10/02/2003 | WO2003080064A1 Kinase inhibitors |
10/02/2003 | WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
10/02/2003 | WO2003080053A1 Combination treatments for chemokine-mediated diseases |
10/02/2003 | WO2003080049A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
10/02/2003 | WO2003080047A1 Phosphate prodrugs of fluorooxindoles |
10/02/2003 | WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts |
10/02/2003 | WO2003080032A2 Pharmaceutical formulation for the active ingredient budesonide |
10/02/2003 | WO2003080029A1 No-donating nsaids adsorbed into carrier particles |
10/02/2003 | WO2003080024A2 Nanoparticulate compositions of map kinase inhibitors |
10/02/2003 | WO2003080020A1 Heat-reversible composition treating hyposalia and asialia |
10/02/2003 | WO2003079988A2 Use of tagatose in laxatives |
10/02/2003 | WO2003079969A2 Compositions and methods for treating and preventing necrosis |
10/02/2003 | WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
10/02/2003 | WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof |
10/02/2003 | WO2003057862A3 Transdifferentiation of pancreatic acinar cells |
10/02/2003 | WO2003042173A8 Nk1 antagonists |
10/02/2003 | WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
10/02/2003 | WO2002092759A3 Molecules for disease detection and treatment |
10/02/2003 | WO2002080852A3 Genes expressed in intestinal epithelium and peyer's patch m cells |
10/02/2003 | WO2002055481A8 Prodrugs of excitatory amino acids |
10/02/2003 | WO2002026781A3 Ige receptor antagonists |
10/02/2003 | WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
10/02/2003 | WO2002018404A9 Nucleoside derivatives for the treatment of hepatitis c |
10/02/2003 | WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives |
10/02/2003 | WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
10/02/2003 | US20030187302 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1H-naphthalene-2 -one oxime |
10/02/2003 | US20030187276 Hydrophobic polyamine analogs and methods for their use |
10/02/2003 | US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders |
10/02/2003 | US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders |
10/02/2003 | US20030187028 Synergistic mixtures; side effect reduction |
10/02/2003 | US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders |
10/02/2003 | US20030187022 Pain management; analgesics |
10/02/2003 | US20030187020 Chemical compounds |
10/02/2003 | US20030187012 Reduction physical cigarette smoking |
10/02/2003 | US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy |
10/02/2003 | US20030187007 Inhibitors of protein kinase for the treatment of disease |
10/02/2003 | US20030186996 Angiogenesis inhibitors |
10/02/2003 | US20030186989 Antihistamines; respiratory system disorders |
10/02/2003 | US20030186988 Lymphocyte disease; autoimmune disease |
10/02/2003 | US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
10/02/2003 | US20030186984 Substituted cyclohexane derivatives |
10/02/2003 | US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases |
10/02/2003 | US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
10/02/2003 | US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens |
10/02/2003 | US20030186964 Piperdines for use as orexin receptor antagonists |
10/02/2003 | US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents |
10/02/2003 | US20030186945 Method of preparing and use of prodrugs of betulinic acid derivatives |
10/02/2003 | US20030186941 Cyclopenteneone derivatives |
10/02/2003 | US20030186933 Preparation of aqueous clear solution dosage forms with bile acids |
10/02/2003 | US20030186894 Dry powder compositions having improved dispersivity |
10/02/2003 | US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders |
10/02/2003 | US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
10/02/2003 | US20030186880 Combination therapy using trefoil peptides |
10/02/2003 | US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family |
10/02/2003 | US20030186434 Method of forming vertebrate pancreas in vitro |
10/02/2003 | US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
10/02/2003 | US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
10/02/2003 | US20030186325 Method of screening for inhibitors of osteopontin |
10/02/2003 | US20030186308 Prostacyclin-stimulating factor-2 |
10/02/2003 | US20030186284 Method of screening ptp ç activitiy promoter or inhibitor |
10/02/2003 | US20030185918 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections |
10/02/2003 | US20030185912 Anti-microbial compositions and methods of using same |
10/02/2003 | US20030185856 Immunizing young hens with antigen proteins of E. coli |
10/02/2003 | US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride |
10/02/2003 | US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
10/02/2003 | US20030185778 Polyamine compounds and compositions for use in conjunction with cancer therapy |
10/02/2003 | CA2756798A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
10/02/2003 | CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors |
10/02/2003 | CA2480384A1 Phenanthridinones as parp inhibitors |
10/02/2003 | CA2480334A1 Hepatocurative effect of emblica officinalis on hepatotoxicity related to cytochrome p-450 |
10/02/2003 | CA2480302A1 Compositions and methods for treating and preventing necrosis |
10/02/2003 | CA2480039A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient |
10/02/2003 | CA2480031A1 Use of tagatose in laxatives |
10/02/2003 | CA2480005A1 Heat-reversible composition treating hyposalia and asialia |
10/02/2003 | CA2479880A1 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
10/02/2003 | CA2479383A1 Storage stable eplerenone formulation |
10/02/2003 | CA2479279A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
10/02/2003 | CA2479277A1 Fused bicyclic pyrimidine derivatives |
10/02/2003 | CA2479256A1 Phosphate prodrugs of fluorooxindoles |
10/02/2003 | CA2479150A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain |
10/02/2003 | CA2478913A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity |
10/02/2003 | CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
10/02/2003 | CA2477651A1 Kinase inhibitors |
10/02/2003 | CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts |